ESRX - Express Scripts Holding Company
| Previous Close | 81.48 |
| Open | 81.27 |
| Bid | 78.58 x 1400 |
| Ask | 83.04 x 1000 |
| Day's Range | 80.50 - 81.43 |
| 52 Week Range | 55.80 - 85.07 |
| Volume | 1,592,984 |
| Avg. Volume | 3,136,585 |
| Market Cap | 45.46B |
| Beta | 1.12 |
| PE Ratio (TTM) | 10.11 |
| EPS (TTM) | 8.01 |
| Earnings Date | Aug 1, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | 2003-11-12 |
| 1y Target Est | 86.06 |
Yahoo Finance Video•14 days agoAmazon PillPack
The Amazon PillPak deal is set but how soon will customers be able to get their prescriptions through the online giant? When Amazon bought Whole Foods shoppers were able to get the discounts the day the deal was done..
Yahoo Finance Video•19 days agoMARKETS: Amazon's buying PillPack—and tanking Walgreens, CVS, Express Scripts stock
Yahoo Finance's Melody Hahm and Jared Blikre break down the latest market action after the world's largest cloud service provider announced a planned purchase of PillPack, expanding Jeff Bezos' ecosystem and demographic spread of future Amazon customers.
- ACCESSWIRE•4 days ago
Free Pre-Market Technical Recap on CVS Health and Three Additional Health Care Plans Stocks
Stock Research Monitor: ESRX, AET, and ANTM LONDON, UK / ACCESSWIRE / July 13, 2018 / If you want a free Stock Review on CVS sign up now at www.wallstequities.com/registration . On Thursday, July 12, 2018, ...
- PR Newswire•4 days ago
WeissLaw LLP Files Class Action Lawsuit Against Express Scripts Holding Company
NEW YORK, July 12, 2018 /PRNewswire/ -- WeissLaw LLP announced that it has filed a class action on behalf of shareholders of Express Scripts Holding Company ("Express Scripts") (ESRX) seeking to pursue remedies under the Securities Exchange Act of 1934 (the "Exchange Act") in connection with the proposed acquisition of Express Scripts by Cigna Corporation ("Cigna"). The class action was commenced in the United States District Court for the Eastern District of Missouri, Eastern Division. On March 8, 2018, Express Scripts and Cigna issued a joint press release announcing that they had entered into a definitive agreement pursuant to which Cigna and Express Scripts will be combined under a new holding company, New Cigna, which will be renamed "Cigna Corporation" immediately after the merger ("Proposed Transaction").
- CNBC•5 days ago
CVS, Aetna shares rise on report DoJ won't challenge their merger deal
Shares of CVS Health and Aetna rose Thursday on a report the Department of Justice won't challenge their merger. Drugstore chain and pharmacy benefits manager CVS announced in December it would acquire health insurer Aetna for $69 billion in a deal that could reshape the health industry. Shares of CVS Health CVS and Aetna AET rose Thursday on a report the Department of Justice won't challenge their merger.
- GlobeNewswire•5 days ago
Express Scripts Holding Company Announces Second Quarter 2018 Earnings Release Details
Express Scripts Holding Company (ESRX) (“Express Scripts”) announced today its intention to release its 2018 second quarter financial results on Wednesday, August 1, 2018, after the market closes. Express Scripts is a healthcare opportunity company.
Markit•5 days agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
Express Scripts Holding Co NASDAQ/NGS:ESRX
- PR Newswire•6 days ago
Express Scripts Named a Best Place to Work for Disability Inclusion
ST. LOUIS, July 11, 2018 /PRNewswire/ -- Express Scripts (ESRX) was again recognized with a 100 percent score on the Disability Equality Index® (DEI) for its ongoing commitment to being inclusive and welcoming to people of all abilities. The DEI is a national benchmarking tool and joint initiative of the American Association of People with Disabilities and the US Business Leadership Network®. "Express Scripts is proud of being a top-ranked company for disability inclusion for the second consecutive year," said Tim Wentworth, CEO and President of Express Scripts.
- Bloomberg•6 days ago
After Feuding With Drug Middlemen, Startup Fields a Competitor
Blink Health, a startup that helps patients shop for low-cost prescription drugs online, has helped set up a new pharmacy-benefit administration firm after big drugstore operators balked at filling orders placed through the service. Blink said on Wednesday that it had partnered with former officials of Express Scripts Holding Co. to create Blue Eagle Health, which it characterized as an alternative to large pharmacy-benefit managers who have been criticized by the Trump administration for their role in driving up drug costs. The venture “is replacing a complicated and opaque” pharmacy-payment system, said Geoffrey Chaiken, Blink’s chief executive officer.
- American City Business Journals•7 days ago
Analyst: Express Scripts will grow alongside Amazon, even after purchase of PillPack
"I think Amazon really isn’t so much taking aim at companies like Express Scripts, they’re really trying to take aim more at the traditional pharmacy market."
- Zacks•8 days ago
M&A Hits Record in 1H: Ride High With These ETFs
Merger and acquisition activities across the globe hit record highs in the first half of 2018 driven by growing ambition of American companies.
- American City Business Journals•12 days ago
OP company files antitrust suit against pharmacy giant
Pharmacy First filed suit against Express Scripts after the company narrowed its network of pharmacy administrators.
InvestorPlace•12 days ago3 Big Stock Charts for Thursday: Express Scripts Holding Co, Alexion Pharmaceuticals and Ventas
Traders looking for higher-odds trading prospects, however, will want to look at Express Scripts Holding Co (NASDAQ:ESRX), Alexion Pharmaceuticals (NASDAQ:ALXN) and Ventas (NYSE:VTR) … each of which are actually getting into a bullish groove despite Tuesday’s lull. The wave of M&A within the healthcare arena, and within the pharmaceutical distribution sliver of the market in particular, has been a blessing and a curse for Express Scripts Holding. • The monthly chart indicates that the bullish move in December not only broke above a falling resistance line that had extended back to 2015’s peak, but has put a string of higher highs and higher lows in place.
Reuters•12 days agoDrugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic
In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs. The latest move by insurers - which effectively forces drug companies to pay more to assist patients with their copays - is causing a decline in real U.S. drug prices this year, and is expected to become more widely adopted in 2019. Among major drugmakers, AbbVie Inc and Amgen Inc have said the most so far about the new tactic, and more drugmakers will likely face questions about it during quarterly earnings calls in July.
- Reuters•12 days ago
FOCUS-Drugmakers try evasion, tougher negotiations to fight new U.S. insurer tactic
In the escalating battle over U.S. prescription drug prices, major pharmaceutical companies are scrambling to limit the economic damage from a new U.S. insurer tactic that coaxes patients away from expensive drugs. The latest move by insurers - which effectively forces drug companies to pay more to assist patients with their copays - is causing a decline in real U.S. drug prices this year, and is expected to become more widely adopted in 2019. Among major drugmakers, AbbVie Inc and Amgen Inc have said the most so far about the new tactic, and more drugmakers will likely face questions about it during quarterly earnings calls in July.
- CNBC•14 days ago
Amazon could start selling prescription drugs as soon as PillPack deal closes
Amazon bought internet pharmacy start-up PillPack last week for around $1 billion. Drug supply chain experts suggest that the company could target the growing niche of people who pay out-of-pocket for their meds. Now that Amazon AMZN has snapped up internet pharmacy PillPack for around $1 billion in cash , how long will it take before consumers can rely on the e-commerce giant for their medicines, as they do for groceries, clothing, books and pretty much everything else?
Markit•17 days agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
This could indicate that investors who seek to profit from falling equity prices are not currently targeting ESRX. Over the last one-month, outflows of investor capital in ETFs holding ESRX totaled $2.06 billion.
- Bloomberg•18 days ago
Five Questions About Amazon’s Play for the $300 Billion Pharmacy Market
Amazon.com Inc. is buying its way into the pharmacy business. PillPack, the startup pharmacy that Amazon is buying for about $1 billion, for now focuses on a narrow segment of patients who are on many different medications. It packages pills in individual packets that help people remember when to take their drugs every day, a common challenge for people taking, for example, drugs for diabetes, high cholesterol and blood pressure.
- Motley Fool•18 days ago
Should Amazon's PillPack Acquisition Frighten Pharmacies?
A decision to enter the mail-order pharmacy business could shake up this massive market.
- Reuters•18 days ago
Amazon to buy PillPack in potentially disruptive drug retail push
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent. PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for multiple complex, chronic conditions.
- PR Newswire•18 days ago
SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Express Scripts Holding Co. - ESRX
NEW YORK , June 28, 2018 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm headquartered at the Empire State Building in New York City ...
- CNBC•19 days ago
Amazon swooped in to buy PillPack for around $1 billion after lead buyer Walmart dragged its feet
Walmart was in talks with PillPack for months. After a report from CNBC, Amazon stepped in with a bid for around $1 billion in cash, sources say. Walmart was poised to buy online pharmacy start-up PillPack before Amazon AMZN swooped in with a higher offer.
- Benzinga•19 days ago
Amazon To Buy Online Pharmacy PillPack; Drug Store Stocks Fall
The pharmaceutical industry needs an ice pack. Amazon.com, Inc. (NASDAQ: AMZN ) struck a blow Thursday with its acquisition of PillPack, an online pharmacy. "PillPack's visionary team has a combination ...
- American City Business Journals•21 days ago
Pharmacy network accuses Express Scripts of anti-competitive practices
Pharmacy First said Monday it filed a federal lawsuit accusing Express Scripts of excluding Pharmacy First from its network along with a majority of other pharmacy services administrative organizations (PSAOs).
Markit•21 days agoSee what the IHS Markit Score report has to say about Express Scripts Holding Co.
Express Scripts Holding Co NASDAQ/NGS:ESRX
